Immuneering Presents Atebimetinib Pancreatic Cancer Data at AACR
NEW YORK — September 28, 2026 Immuneering Corporation presented new data at the 2026 AACR Conference on Pancreatic Cancer...
cancer cachexia
Advertisement
Artelo Files Patent for ART27.13 in Obesity
SOLANA BEACH, Calif. — September 23, 2026 Artelo Biosciences announced that it has filed a new provisional patent application...
Artelo Biosciences Secures U.S. Patent Allowance for ART27.13
Solana Beach, California — August 17, 2026 Artelo Biosciences, Inc. announced that the U.S. Patent and Trademark Office (USPTO)...
Spineart Gains FDA Approval for BAGUERA C Cervical Disc
Geneva, Switzerland, August,11, 2026 Spineart has announced that its BAGUERA® C cervical disc has received U.S. Food and Drug...
Kalohexis Appoints Jeffrey Sherman to Board of Directors
Northbrook, Illinois, August,11, 2026 Kalohexis, Inc., a clinical-stage biotechnology company developing therapies that target the melanocortin system, has appointed...
Advertisements
Headline (SEO-Optimized, ≤60 characters):Actimed Secures Key Japan Patent for Muscle-Wasting Drug
London, UK – November 3, 2025 Actimed Therapeutics Ltd, a UK-based clinical-stage specialty pharmaceutical company, has announced the grant...
Advertisement
